References
- Fujii TM, Kowa Y. [Teratogenesis of azathioprine (Imuran) in mice and rats]. Oyo Yakuri 1968; 2: 401.
- Githens JH, Rosencrantz JG. Tunnock SM. Teratogenic effects of azathioprine (Imuran). J Pediatr 1965; 66: 962–3.
- Tuchman-Duplessis H, Mercier-Parot L. Production de malformations des membres chez le lapin par administrations d'un antimetabolite: l'azathioprine. CR Acad Sci YEAR??? 259: 3648–51.
- Saarikoski S, Seppala M. Immunosuppression during pregnancy; transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973; 115: 1100–6.
- Rudolph JE, Schweizer RT, Bartkus SA. Pregnancy in renal transplant patients. Transplantation 1979: 27: 26–9.
- The Registration Committee of the European Dialysis and Transplant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol 1980; 87: 839–45.
- Ramsey-Goldman R, Mientus JM, Kutzer JE, Mulvihill JJ, Medsger J TA. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 1993; 20: 1152–7.
- Davison JM et al. Maternal azathioprine therapy and depressed hematopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985; 92: 233–9.
- Monie IW. Chlorambucil-induced abnormalities of urogenital system of rat fetuses. Anat Rec 1961; 139: 145.
- Brummett ES, Johnson EM. Morphological alterations in the developing fetal rat limb due to maternal injection of chlorambucil. Teratology 1979; 20: 279–88.
- Sokal JE, Lessmann EM. Effects of cancer chemother- apeutic agents on the human fetus. JAMA 1960; 172: 1765–71.
- Shotton D, Monie IW. Possible teratogenic effect of chlorambucil on a human fetus. JAMA 1963; 186: 74–5.
- Steege JF, Caldwell DS. Renal agenesis after first trimester exposure to chlorambucil. South Med J 1980; 73: 1414–5.
- David J, Vouyiouka O, Ansell BM, Hall A, Woo P. Amy-oidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993; 11: 85–90.
- Chaube S, Kury G, Murphy ML. Teratogenic effects of cyclophosphamide in the rat. Cancer Chemother Biol Response Modif 1967; 51: 363–76.
- Fritz H, Hess R. Effects of cyclophosphamide on embryonic development in the rabbit. Agents Actions 1971; 2: 83–6.
- Wilk AL, McClure HM, Horigan EA. Induction of craniofacial malformations in the rhesus monkey with cyclophosphamide. Teratology 1978; 17: 24A.
- Kirshon B, Wasserstrum N, Wilis R, Herman GE, McCabe ERB. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 1988; 72: 462–4.
- Martinez-Rueda JO, Arce-Salinas CA, Kraus A, Alcocer- Varela J, Alarcon-Segovia D. Factors associated with fetal losses in severe systemic lupus erythematosus. Lupus 1996; 5: 113–9.
- Pizzuto J et al. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 1980; 64: 679–83.
- Schmid BP. Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptop-urine, methotrexate, or cyclosporine A. Toxicology 1984; 31: 9–21.
- Skalko RG, Gold MP. Teratogenicity of methotrexate in mice. Teratology 1974; 9: 159–64.
- Zamenhof S. Differential effects of antifolate on the development of brain parts in chick embryos. Growth 1985; 49: 28–33.
- Adams CE, Hay MF, Lutwak-Mann C. The actions of various agents on the rabbit embryo. Journal of Embryology and Experimental Morphology 1961; 9: 468–91.
- Wilson JG et al. Comparative distribution and embryotoxicity of methotrexate in pregnant rats and Rhesus monkeys. Teratology 1979; 19: 71–80.
- Briggs, Freeman, Yaffee. Drugs in Pregnancy and Lactation. 3rd ed. Baltimore: Williams and Wilkins, 1990.
- Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990; 88: 589–92.
- Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1998; 40: 971–3.
- Østensen M. Treatment with low dose methotrexate in early pregnancy. Rheumatology in Europe 1998; 26(Suppl. 2): 40.
- Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K, Kinashi M, et al. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 1994 April; 37: 551–8.
- Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989; 150: 613–9.